What is the recommended dose of ivermectin (antiparasitic medication) for a breastfeeding mother of a 4-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ivermectin Dosing in Breastfeeding Mothers

The recommended dose of ivermectin for a breastfeeding mother is 200 mcg/kg orally as a single dose, repeated in 2 weeks, and breastfeeding should continue without interruption. 1

Standard Dosing Regimen

The Centers for Disease Control and Prevention recommends 200 mcg/kg orally, repeated in 2 weeks for most parasitic infections including scabies, which is the most common indication. 2, 1 For a typical adult weighing 56 kg, this translates to approximately 12 mg (four 3-mg tablets) as a single dose, then repeated after 14 days. 1

Critical Administration Instructions

  • Take ivermectin with food to increase bioavailability by 2.5 times and enhance drug penetration into the epidermis. 2, 1
  • The second dose at 2 weeks is mandatory because ivermectin has limited ovicidal activity and cannot prevent recurrence from eggs present at the time of initial treatment. 2, 1

Safety During Breastfeeding

Ivermectin is compatible with breastfeeding and lactation should not be interrupted. 2 Multiple lines of evidence support this recommendation:

  • The CDC classifies ivermectin as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding. 2, 1
  • Very low levels are excreted into breastmilk, making it likely compatible with breastfeeding. 2
  • Actual measured concentrations in breastmilk after a 200 mcg/kg dose ranged from 1.4 to 20.8 ng/ml (mean 9.26 ng/ml), resulting in infant exposure of only 1.1 mcg/kg—which is 0.55% of the weight-adjusted maternal dose. 3
  • This exposure level is far below the World Health Organization threshold for safe breastfeeding. 3
  • Earlier studies measuring ivermectin in breastmilk after 150 mcg/kg doses found steady-state levels were low, with mean milk concentrations of 14.13 ng/ml. 4

Special Considerations for the 4-Month-Old Infant

While the mother can safely breastfeed, the 4-month-old infant should NOT receive direct ivermectin treatment if needed for their own parasitic infection. 2, 1

  • Infants and young children should be treated with permethrin topical therapy instead of ivermectin. 2, 1
  • Safety in children weighing <15 kg has not been fully established for direct treatment. 1
  • However, exposure through breastmilk at the levels described above is considered safe. 3, 4

Dosing Adjustments

  • No dose adjustment is required for renal impairment. 2, 1
  • Use with extreme caution in severe liver disease, as the safety of multiple doses has not been established in this population. 2, 1

Critical Pitfalls to Avoid

  • Do not skip the second dose at 2 weeks—this is mandatory for treatment success due to limited ovicidal activity. 2, 1
  • Do not take on an empty stomach—food significantly increases bioavailability and therapeutic efficacy. 2, 1
  • Do not interrupt breastfeeding—the minimal drug transfer to breastmilk poses no risk to the infant. 2, 3
  • Treat all household and sexual contacts simultaneously within the previous month to prevent reinfection. 2, 1
  • Understand that symptoms may persist for up to 2 weeks after successful treatment due to allergic dermatitis, not treatment failure. 1

References

Guideline

Ivermectin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ivermectin levels in human breastmilk.

European journal of clinical pharmacology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.